SCHEMBL31132497

SCHEMBL31132497

CC(C)(C)OC(=O)N1CC2CCC(C1)N2C(=O)c1ccc(=O)[nH]c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.46
▸ SPR P35270 2/20 0.44
▸ TRPV6 Q9H1D0 1/20 0.44
▸ HPGD P15428 1/20 0.42
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HSD11B1 P28845 1/20 0.40
▸ USP30 Q70CQ3 2/20 0.40
▸ HCAR1 Q9BXC0 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ FPR2 P25090 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ RIN1 Q13671 1/20 0.38
▸ DDB1 Q16531 1/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ LIPE Q05469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31133057 0.80 KMT2A (0.59) GPR119KDM4ETRPV6MAPTTHRB
SCHEMBL27143853 0.80 KDM4E (0.50) GPR119KDM4ESPRHSD11B1USP30
SCHEMBL31132453 0.77 SETD7 (0.61) GPR119KDM4ESPRTRPV6HPGD
Hydrochloric Acid SCHEMBL30020380 0.76 KDM4E (0.47) GPR119KDM4ESPRHSD11B1USP30
SCHEMBL27150678 0.76 KDM4E (0.44) GPR119KDM4ESPRHSD11B1USP30
SCHEMBL31133156 0.74 TRPV6 (0.50) KDM4ETRPV6HPGDMAPTKMT2A
SCHEMBL31132494 0.73 GPR119 (0.47) GPR119KDM4ESPRTRPV6MAPT
SCHEMBL31132989 0.72 GPR119 (0.46) GPR119KDM4ESPRTRPV6USP30
SCHEMBL21526591 0.71 HSD11B1 (0.48) GPR119SPRHSD11B1KMT2AMEN1
SCHEMBL31267584 0.71 HSD11B1 (0.48) GPR119SPRHSD11B1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704830-A2 MRGPRX2 INHIBITORS AND METHODS OF USE THEREOF Septerna, Inc. (US) 2026-03-11 — — EP disclosed
WO-2024226914-A2 MRGPRX2 ANTAGONISTS AND METHODS OF USE THEREOF SEPTERNA, INC. (US) 2024-10-31 — — WO disclosed
Send feedback